ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Five Institutions To Test Interferon; Appendectomy-Cancer Association Noted

October 27, 1978

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

Shingleton Nominated To President’s Panel

June 10, 1977

Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees

January 6, 1984

Soybean Studies, Computing Support Recompetition Ok’d

November 9, 1990

President’s Budget: $64 Million Cut for NCI, No Start On Year 2000 goals, Drop 240 Grants In 1985

February 8, 1985